crohn's disease by sat
TRANSCRIPT
-
8/2/2019 Crohn's Disease by SAT
1/21
Crohn'sCrohn's DDiseaseisease
endy Satrya Kurniawanendy Satrya Kurniawan
-
8/2/2019 Crohn's Disease by SAT
2/21
Definition
Crohn's disease is a chronic, idiopathicinflammatory disease with a propensity to affectthe distal ileum, although any part of thealimentary tract can be involved
United States : 3.6 to 8.8 per 100,000 there are 2-fold to 4- fold increased prevalence in
Ashkenazi Jewish
females > males.
The median age at which patients are diagnosedapproximately 30 years; however, age ofdiagnosis can range from early childhoodthrough the entire life span.
-
8/2/2019 Crohn's Disease by SAT
3/21
Higher socioeconomic status increased risk
Most studies have found breast-feeding to beprotective against the development of Crohn's
disease. Crohn's disease is more prevalent among
smokers. Furthermore, smoking is associatedwith the increased risk for both the need for
surgery and the risk of relapse after surgeryfor Crohn's disease.
-
8/2/2019 Crohn's Disease by SAT
4/21
Pathophysiology
Crohn's disease is characterized by sustainedinflammation.
Various hypotheses on the roles of environmental andgenetic factors in the pathogenesis of Crohn's diseasehave been proposed.
Many infectious agents have been suggested to be thecausative organism of Crohn's disease.
Chlamydia,
Listeria monocytogenes,
Pseudomonas species, reovirus,
Mycobacterium paratuberculosis, and many others.
-
8/2/2019 Crohn's Disease by SAT
5/21
a variety of defects in immune regulatorymechanisms, e.g., overresponsiveness ofmucosal T cells to enteric flora-derived
antigens, can lead to defective immunetolerance and sustained inflammation
Specific genetic defects associated with Crohn'sdisease
For example, the presence of a locus onchromosome 16 (the so-called IBD1 locus)has been linked to Crohn's disease. The IBD1locus has been identified as the NOD2gene.
Pathophysiology
-
8/2/2019 Crohn's Disease by SAT
6/21
Pathology
The earliest lesion characteristic is the aphthousulcer. These superficial ulcers are up to 3 mm in
diameter and are surrounded by a halo oferythema. In the small intestine, aphthous ulcerstypically arise over lymphoid aggregates.
Granulomas are highly characteristic of Crohn'sdisease up to 70% of intestinal specimensobtained during surgical resection
-
8/2/2019 Crohn's Disease by SAT
7/21
As disease progresses, aphthae coalesce into larger, stellate-shaped ulcers, linear or serpiginous
ulcers.
With advanced disease, inflammation can be transmural.Serosal involvement results in adhesion of theinflamed bowel to other loops of bowel or otheradjacent organs.
Transmural inflammation also can result in fibrosis, with
stricture formation, intra-abdominal abscesses,fistulas, and, rarely, free perforation.
Inflammation in Crohn's disease can affect discontinuousportions of intestine: so-called "skip lesions" that areseparated by intervening normal-appearing intestine.
Pathology
-
8/2/2019 Crohn's Disease by SAT
8/21fat wrapping
-
8/2/2019 Crohn's Disease by SAT
9/21
Crohn's disease vs ulcerative colitis :
inflammation in ulcerative colitis is limitedto the mucosa and submucosa but may
involve the full thickness of the bowelwall in Crohn's disease
inflammation is continuous andcharacteristically affects the rectum in
ulcerative colitis but may bediscontinuous and spare the rectum inCrohn's disease
-
8/2/2019 Crohn's Disease by SAT
10/21
-
8/2/2019 Crohn's Disease by SAT
11/21
Clinical Presentation
Signs and symptoms of Crohn's disease can range from mildto severe and may develop gradually or come on suddenly,without warning. They include:
Diarrhea
Abdominal pain and cramping
Blood in your stool
Ulcers-
Reduced appetite and weight loss
Fistula or abscess
-
8/2/2019 Crohn's Disease by SAT
12/21
The distal ileum is the single most frequentlyaffected site, being diseased at some time in
75% of patients with Crohn's disease.
The small bowel alone is affected in 15 to 30%of patients,
Both the ileum and colon are affected in 40 to60% of patients
Colon alone is affected in 25 to 30% of patients.
Isolated perineal and anorectal disease occurs
in 5 to 10% of affected patients. Uncommon sites of involvement include the
esophagus, stomach, and duodenum.
-
8/2/2019 Crohn's Disease by SAT
13/21
25% of all patients with Crohn's disease will havean extraintestinal manifestation
Erythema nodosum, Pyoderma gangrenosum Peripheral arthritis, Ankylosing spondylitis, Sacroiliitis Conjunctivitis, Uveitis/iritis Hepatic steatosis, Cholelithiasis Primary sclerosing cholangitis, Pericholangitis Nephrolithiasis
Thromboembolic disease, Osteoporosis Endocarditis, myocarditis, pleuropericarditis Interstitial lung disease Amyloidosis, Pancreatitis
Clinical Presentation
-
8/2/2019 Crohn's Disease by SAT
14/21
Pyoderma gangrenosum
-
8/2/2019 Crohn's Disease by SAT
15/21
Diagnosis
acute or chronic abdominal pain, especially theright lower quadrant,
chronic diarrhea,
evidence of intestinal inflammation onradiography or endoscopy,
the discovery of a bowel stricture or fistulaarising from the bowel,
and evidence of inflammation or granulomas onintestinal histology.
radiographic, endoscopic, and pathologic tests
-
8/2/2019 Crohn's Disease by SAT
16/21
CROHNS DISEASE
Contrast radiographdemonstrating that the lumen
of the terminal ileum isnarrowed and markedlyseparated from thesurrounding small bowel by athickened wall. There are
skip lesions in the colon thathave a cobblestoneappearance.
-
8/2/2019 Crohn's Disease by SAT
17/21
Management
Because no curative therapies are available forCrohn's disease, the goal of treatment is topalliate symptoms rather than to achieve cure.
Medical therapy is used to induce and maintaindisease remission.
Surgery is reserved for specific indications
In addition, nutritional support in the form of
aggressive enteral regimens or, if necessary,parenteral nutrition, is used to manage themalnutrition that is common in patient's withCrohn's disease.
-
8/2/2019 Crohn's Disease by SAT
18/21
Medical Therapy
Pharmacologic agents used to treatCrohn's disease :
Antibiotics
Aminosalicylates (sulfasalazine)
Corticosteroids
Immunomodulators
-
8/2/2019 Crohn's Disease by SAT
19/21
Surgical Therapy
Seventy to 80% of patients with Crohn's diseasewill ultimately require surgical therapy for theirdisease
Surgery is generally reserved for patients whosedisease is unresponsive to aggressive medicaltherapy or who develop complications
One-third of patients with Crohn's disease will
require surgery for intestinal obstruction.Abscesses and fistulas are frequentlyencountered during operations performed forintestinal obstruction in these patients,
-
8/2/2019 Crohn's Disease by SAT
20/21
-
8/2/2019 Crohn's Disease by SAT
21/21
...thankyou...